Companies / Impact Biomedical Inc.

Impact Biomedical Inc.

NYSE: IBOCIK 1834105HOUSTON, TX

Financials · FY2025

Revenue$32.0K
Net income$-11.87M
Total debt$11.90M
Cash$20.0K
Diluted EPS$-0.38
Shares outstanding107.8M

Ownership

107.8M shares outstanding · as of Aug 4, 2026
0.38%Insiders
Ownership
Insiders0.38%405,304
10%+ / strategic0.51%545,024
Institutions2.92%3,153,227
Public float96.19%103,717,676

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Dss, Inc.10% owner
0.51%545,024
Grady JasonDirector
0.23%250,182
Macko Todd DChief Financial Officer
0.14%155,122

Institutional holders 25

View all →
HolderValue% of shares
Geode Capital Management, LLC$716.2K1.11%
Vanguard Group Inc$411.5K0.76%
State Street Corporation$279.6K0.56%
BlackRock, Inc.$119.6K0.24%
Millennium Management LLC$69.6K0.13%
Two Sigma Investments, LP$22.5K0.03%
Two Sigma Securities, LLC$11.5K0.02%
Susquehanna International Group, LLP$8.3K0.02%
Jane Street Group, LLC$7.1K0.01%
Northern Trust Corp$5.2K<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 22, 2025Dss, Inc.
10% owner
SellCommon Stock$63.5K-116K
-16.37%
590,424
0.55% of shares
low
Mar 23, 2026Grady Jason
Director
SellCommon Stock$32.5K-50K
-16.66%
250,182
0.23% of shares
low
May 27, 2025Dss, Inc.
10% owner
SellCommon Stock$24.5K-45K
-7.69%
545,024
0.51% of shares
low
Mar 27, 2026Macko Todd D
Executive
SellCommon Stock$24.4K-43K
-21.86%
155,122
0.14% of shares
low
Mar 25, 2026Macko Todd D
Executive
SellCommon Stock$961-2K
-0.80%
198,122
0.18% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IBOCommon StockEquity45259L205BBG01JFZG014